Letter to the Editor[68Ga]Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction
Under an Elsevier user license
open archive
Cited by (0)
Please note: Please see the paper by Thackeray (page 1417) and the accompanying editorial comment by Nahrendorf and Swirski (page 1427) in this issue. Dr. Ertl is a consultant for Novartis. Dr. Wester is the chief executive officer of and shareholder in Scintomics. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Drs. Lapa and Reiter contributed equally to this work as first authors. Drs. Bauer and Herrmann contributed equally as senior authors.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.